NEWS & BUZZ ABOUT HENGRUI
11/18/2020
|
Hengrui Announced First Patient Dosed with Pyrotinib in PYRAMID-I Phase 3 Pivotal Trial in the United States on November 18th, 2020
|
11/18/2020
|
Hengrui Announced First Patient Dosed with Pyrotinib in PYRAMID-I Phase 3 Pivotal Trial in the United States on November 18th, 2020
|